Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Jon9800


V.IBO

UI CEO’s joyous to work with Blue Digital Media

"We are happy to have access to Blue Digital's distribution channels...

July 7, 2022

V.IBO

$IBOGF and its approaching advanced addiction treatment prot

UI is developing a progressive and comprehensive addiction treatment protocol...

July 6, 2022

V.IBO

Blue digital media to proficiently broaden the $IBOGF story

The UI story will be distributed through numerous platforms and audiences by...

July 6, 2022

V.HEM

Existing shareholder exemption of the Hemostemix offer

The offering constituting the private non-brokered placement of 15 Million...

July 4, 2022

V.HEM

$HEM employs a popular financial advisor to the CEO

$HEM has been welcomed as a special financial MR. Rick Groome advisor to...

July 4, 2022

V.HEM

Data audit efficiently executed, results came out to be auth

Hemostemix have been handed back its intellectual property consisting of all...

July 4, 2022

V.HEM

Market Cap Margin

Over the brief outlook of $ADD, the company has surpassed a 19.7 million...

July 4, 2022

V.HEM

$HEM outstanding shares and public float idea

$HMTXF has successfully offered and issued an aggregate of 68.2 Million to...

July 4, 2022

V.HEM

Efficacy of NCP-01 a futuristic product by Hemostemix

Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem...

July 4, 2022

V.HEM

$HMTXF common share and warrant elaboration

The recently announced private placement of 15 million units has put the...

July 1, 2022

V.HEM

Potential capability of NCP-01 by Hemostemix

Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem...

July 1, 2022

V.HEM

$IBOGF announced a crucial addition of clinical trials direc

Julie Dumouchel has been named Director of Clinical Trials at UI, which is a...

June 30, 2022

V.HEM

$IBOGF CO-founder to present his findings at a global summit

The company recently announced that DR Alberto Sola, CO-Founder Universal...

June 30, 2022

V.HEM

$HEM perfect patent record and universal acknowledgement

$HEM owns a total of 91 patents in 5 different categories falling under 25...

June 30, 2022

V.HEM

CEO Hemostemix highlighted the mounting demand of $HEM.

Thomas Smeenk on the latest update stated “for the stem cell space it is the...

June 30, 2022

V.HEM

Efficacy of NCP-01 a futuristic product by Hemostemix

Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem...

June 30, 2022

V.HEM

$HMTXF average volume expenditure analysis

$HMTXF offers a sum of approx 22,798 for daily trade and investor related...

June 29, 2022

V.HEM

regains lawful possession of all its missing intellectual pr

All the intellectual data including all phase 2 clinical trial data, all the...

June 29, 2022

V.HEM

Hemostemix dissolves all pending lawsuits with Aspire health

The long awaited moment for hemostemix has finally come. The company just got...

June 29, 2022

V.HEM

Hemostemix hires new financial advisor to the family

Mr. Rick Groome who has effectively settled 2 securities firm, helping many...

June 29, 2022

Prev 1 2 3 4 5 Next